Seoul National University Hospital
Seoul, Other, 03080, South Korea
NCT Number: NCT04364945
In this study, we compared the results of the intelligence and behavioral test performed after surgery between the group using sevoflurane and the group receiving dexmedetomidine and remifentanil, in Korean children under 2 years of age who underwent surgery under general anesthesia.
This study is active but is not currently recruiting participants.
1 month–23 month
All sexes
Interventional
Not applicable
Seoul, Other, 03080, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
administration of dexmedetomidine 1 mcg/kg/hr
administration of remifentanil 0.1-0.2 mcg/kg/min
Anesthesia is maintained using sevoflurane.
Time frame: When the patient's age is 5 years after surgery
categorization: 130 and above: Very Superior 120-129: Superior 110-119: High Average 90-109: Average 80-89: Low Average 70-79: Borderline
Time frame: When the patient's age is 30 months old after surgery
Korean version of the Leiter International Performance Scale-Revised (Leiter-R), categorization:
130 and above: Very Superior 120-129: Superior 110-119: High Average 90-109: Average 80-89: Low Average 70-79: Borderline
Time frame: When the patient's age is 7 years old after surgery
categorization: 130 and above: Very Superior 120-129: Superior 110-119: High Average 90-109: Average 80-89: Low Average 70-79: Borderline
Time frame: When the patient's age become 30 months, 5 years and 7 years old after surgery
Child Behavior Checklist results at age of 30 months, 5 years and 7 years
Seoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01949662
Advanced Cancers, Chemically-Induced Disorders
Houston, Texas, United States
View Trial DetailsNCT02481336
Chemically-Induced Disorders, Nervous System Diseases
Tainan, Taiwan
View Trial DetailsNCT04514029
Chemically-Induced Disorders, Hemic and Lymphatic Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT03696784
Chemically-Induced Disorders, Cytokine Release Syndrome
Chapel Hill, North Carolina, United States
View Trial Details